Stock GNMK GENMARK DIAGNOSTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Highlights GenMark Diagnostics, Inc.

Equities

GNMK

US3723091043

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Roche Holding AG completed the acquisition of GenMark Diagnostics, Inc..
CI
Roche : Opens $1.8 Billion Tender Offer for GenMark Diagnostics
MT
GenMark Diagnostics : Roche's Planned Acquisition of GenMark Diagnostics 'Makes Strategic Sense,' Needham Says
MT
GenMark Diagnostics : Roche to Acquire GenMark Diagnostics for $1.8 Billion in Cash
MT
BioMerieux : Roche buys GenMark for $1.8 million to challenge test rivals
RE
Roche : Strikes $1.8 Billion Deal to Buy GenMark as COVID-19 Test Demand Seen Increasing
MT
GenMark Diagnostics : Agrees to be Bought by Roche for $24.05 Per Share in Cash
MT
Roche : Signs Merger Agreement to Acquire GenMark Diagnostics
DJ
GenMark Diagnostics : Roche agrees to buy GenMark Diagnostics in $1.8 billion deal
RE
Roche : Enters $1.8 Billion Acquisition Deal For US-based GenMark Diagnostics
MT
Roche Holding AG entered into a definitive merger agreement to acquire GenMark Diagnostics, Inc. for $1.9 billion.
CI
Genmark Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
GenMark Diagnostics : Earnings Flash (GNMK) GENMARK DIAGNOSTICS Posts Q4 Revenue $50.1M, vs. Street Est of $49.1M
MT
GenMark Diagnostics : Earnings Flash (GNMK) GENMARK DIAGNOSTICS Reports Q4 EPS $-0.05, vs. Street Est of $-0.02
MT
GenMark Diagnostics, Inc. Provides Earnings Guidance for the Year 2021
CI
GenMark Diagnostics, Inc. ePlex RP2 Panel Predicted to Detect Known SARS-CoV-2 Variants Currently in Circulation Based on in silico Analysis
CI
GenMark Diagnostics, Inc. Announces Study Highlights Potential Clinical Value of ePlex® Blood Culture ID Panels
CI
GenMark Reportedly Explores Sale Amid Interest
CI
GenMark Diagnostics : Projects Higher Q4 Revenue; Shares Up 8% After-Hours
MT
GenMark Diagnostics, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GNMK Stock
  4. News GenMark Diagnostics, Inc.
  5. Highlights